Publications

  • Birk AV, Dubovi EJ, Zhang X, Szeto HH. Antiviral activity of geneticin against bovine viral diarrhoea virus. Antivir Chem Chemother. 2008;19(1):33-40. PMID: 18610556
  • Birk AV, Dubovi EJ, Cohen-Gould L, Donis R, Szeto HH. Cytoplasmic vacuolization responses to cytopathic bovine viral diarrhoea virus. Virus Res. 2008 Mar;132(1-2):76-85. Epub 2007 Dec 3. PMID: 18054406
  • Whiteman M, Spencer JP, Szeto HH, Armstrong JS. Do mitochondriotropic antioxidants prevent chlorinative stress-induced mitochondrial and cellular injury? Antioxid Redox Signal. 2008 Mar;10(3):641-50. PMID: 18052717
  • Szeto HH. Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal. 2008 Mar;10(3):601-19. Review. PMID: 17999629
  • Pena A, Murat B, Trueba M, Ventura MA, Bertrand G, Cheng LL, Stoev S, Szeto HH, Wo N, Brossard G, Serradeil-Le Gal C, Manning M, Guillon G. Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors. Endocrinology. 2007 Sep;148(9):4136-46. Epub 2007 May 10. PMID: 17495006
  • Cho J, Won K, Wu D, Soong Y, Liu S, Szeto HH, Hong MK. Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coron Artery Dis. 2007 May;18(3):215-20. PMID: 17429296
  • Pena A, Murat B, Trueba M, Ventura MA, Wo NC, Szeto HH, Cheng LL, Stoev S, Guillon G, Manning M. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8. J Med Chem. 2007 Feb 22;50(4):835-47. PMID: 17300166
  • Cho S, Szeto HH, Kim E, Kim H, Tolhurst AT, Pinto JT. A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J Biol Chem. 2007 Feb 16;282(7):4634-42. Epub 2006 Dec 18. PMID: 17178711
  • Thomas DA, Stauffer C, Zhao K, Yang H, Sharma VK, Szeto HH, Suthanthiran M. Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function. J Am Soc Nephrol. 2007 Jan;18(1):213-22. Epub 2006 Dec 6. PMID: 17151329
  • Szeto HH. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J. 2006 Aug 18;8(3):E521-31. Review. PMID: 17025271
  • Petri S, Kiaei M, Damiano M, Hiller A, Wille E, Manfredi G, Calingasan NY, Szeto HH, Beal MF. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. J Neurochem. 2006 Aug;98(4):1141-8. PMID: 16895581
  • Szeto HH. Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J. 2006 Apr 21;8(2):E277-83. Review. PMID: 16796378
  • Stoev S, Cheng LL, Manning M, Wo NC, Szeto HH. Design and synthesis of potent, highly selective vasopressin hypotensive agonists. J Pept Sci. 2006 Sep;12(9):592-604. PMID: 16625682
  • Zhao K, Luo G, Giannelli S, Szeto HH. Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem Pharmacol. 2005 Dec 5;70(12):1796-806. Epub 2005 Oct 10. PMID: 16216225
  • Guillon G, Pena A, Murat B, Derick S, Trueba M, Ventura MA, Szeto HH, Wo N, Stoev S, Cheng LL, Manning M. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity. J Pept Sci. 2006 Mar;12(3):190-8. PMID: 16130178
  • Manning M, Cheng LL, Stoev S, Wo NC, Chan WY, Szeto HH, Durroux T, Mouillac B, Barberis C. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban. J Pept Sci. 2005 Oct;11(10):593-608. PMID: 15880385
  • Shimoyama M, Kuwaki T, Nakamura A, Fukuda Y, Shimoyama N, Schiller PW, SSzeto HH. Differential respiratory effects of [Dmt1]DALDA and morphine in mice. Eur J Pharmacol. 2005 Mar 28;511(2-3):199-206. PMID: 15792789
  • Szeto HH, Schiller PW, Zhao K, Luo G. Fluorescent dyes alter intracellular targeting and function of cell-penetrating tetrapeptides. FASEB J. 2005 Jan;19(1):118-20. Epub 2004 Oct 15. PMID: 15489247
  • Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW, Szeto HH. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem. 279(33):34682-90, 2004.
  • Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A. 101(14):5135-9, 2004.
  • Wan H, Umstot ES, Szeto HH, Schiller PW, Desiderio DM. Quantitative analysis of [Dmt(1)]DALDA in ovine plasma by capillary liquid chromatography-nanospray ion-trap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 803(1):83-90, 2004. Other Publications

Back to topBack To Top